{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:35:39Z","timestamp":1777347339280,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.semnephrol.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,12,10]],"date-time":"2010-12-10T09:15:03Z","timestamp":1291972503000},"page":"534-547","source":"Crossref","is-referenced-by-count":43,"title":["Electrolyte Disturbances and Acute Kidney Injury in Patients With Cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Norbert","family":"Lameire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2010.09.002_bib1","series-title":"Biological basis of geriatric oncology","first-page":"89","article-title":"Age and co-morbidity in cancer patients: a population-based approach","author":"Janssen-Heijnen","year":"2005"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI103712","article-title":"Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water","volume":"37","author":"Edelman","year":"1958","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.semnephrol.2009.03.005","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"29","author":"Decaux","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.semnephrol.2009.03.004","article-title":"Epidemiology of hyponatremia","volume":"29","author":"Upadhyay","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s005200050284","article-title":"A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis","volume":"8","author":"Berghmans","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","article-title":"Mortality after hospitalization with mild, moderate, and severe hyponatremia","volume":"122","author":"Waikar","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1681\/ASN.2007070752","article-title":"Medical costs of abnormal serum sodium levels","volume":"19","author":"Shea","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib8","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/cc8016","article-title":"Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database","volume":"13","author":"Hampshire","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3121\/cmr.2007.762","article-title":"Tumor-related hyponatremia","volume":"5","author":"Onitilo","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00520-007-0309-9","article-title":"Diagnosis and management of hyponatremia in cancer patients","volume":"15","author":"Raftopoulos","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.semnephrol.2009.03.002","article-title":"The treatment of hyponatremia","volume":"29","author":"Sterns","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib14","first-page":"70","article-title":"Fluid, electrolyte, and acid-base disturbances","volume":"8","author":"Palmer","year":"2009","journal-title":"NephSAP"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2796.1995.tb00907.x","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease","volume":"238","author":"Sorensen","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib16","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.amjmed.2008.01.038","article-title":"Idiopathic hyponatremia in a young patient: look at the sinus","volume":"121","author":"Renneboog","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2009.263","article-title":"Is it cerebral or renal salt wasting?","volume":"76","author":"Maesaka","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1681\/ASN.2008010089","article-title":"When is it appropriate to use vasopressin receptor antagonists?","volume":"19","author":"Lehrich","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jcem.82.4.3900","article-title":"Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"82","author":"Saito","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib21","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2215\/CJN.00160106","article-title":"Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR 121463B), an orally active nonpeptide vasopressin V2-receptor antagonist","volume":"1","author":"Soupart","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e31817b8148","article-title":"Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"337","author":"Annane","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","article-title":"Hypernatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2009.01.006","article-title":"Acute myeloid leukemia and diabetes insipidus with monosomy 7","volume":"190","author":"Harb","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1600-0609.2002.02763.x","article-title":"Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7","volume":"69","author":"Muller","year":"2002","journal-title":"Eur J Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2010.09.002_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000073351","article-title":"Side effects of ifosfamide","volume":"65","author":"Klastersky","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mpo.10336","article-title":"Chronic ifosfamide nephrotoxicity in children","volume":"41","author":"Skinner","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00043426-200407000-00004","article-title":"Amphotericin B nephrotoxicity in children","volume":"26","author":"Goldman","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2007.04.016","article-title":"Causes and mechanisms of acid-base and electrolyte abnormalities in cancer patients","volume":"19","author":"Miltiadous","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib31","first-page":"447","article-title":"Hypovolemia and dehydration in the oncology patient","volume":"4","author":"Berk","year":"2006","journal-title":"J Support Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/bmj.282.6269.1034","article-title":"Exaggerated hypokalaemia in acute myeloid leukaemia","volume":"282","author":"Adams","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000086055","article-title":"Cisplatin-associated nephrotoxicity and pathological events","volume":"148","author":"Taguchi","year":"2005","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib34","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1093\/ndt\/gfm471","article-title":"Hypokalaemia and subsequent hyperkalaemia in hospitalized patients","volume":"22","author":"Crop","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00228-001-0390-9","article-title":"Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?","volume":"57","author":"Ural","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jcp.41.5.494","article-title":"Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients","volume":"41","author":"Smith","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib37","first-page":"660","article-title":"Pseudohyperkalemia and extreme leukocytosis","volume":"85","author":"Bellevue","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.resuscitation.2005.11.002","article-title":"Potassium disorders\u2014clinical spectrum and emergency management","volume":"70","author":"Alfonzo","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpo.10335","article-title":"Cisplatin nephrotoxicity affects magnesium and calcium metabolism","volume":"41","author":"Goren","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib40","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib41","first-page":"3063","article-title":"Frequency of hypomagnesemia and hypermagnesemia","volume":"263","author":"Whang","year":"1990","journal-title":"Requested vs routineJAMA"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.semnephrol.2003.08.015","article-title":"Hypercalcemia of malignancy","volume":"24","author":"Body","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/jpm.2010.9894","article-title":"Hypercalcemia of malignancy","volume":"13","author":"Siddiqui","year":"2010","journal-title":"J Palliat Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4158\/EP.12.5.535","article-title":"Causes of hypercalcemia in a population of military veterans in the United States","volume":"12","author":"Newman","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000441-200603000-00002","article-title":"Hypercalcemia in the emergency department","volume":"331","author":"Lee","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0889-8588(05)70367-1","article-title":"Hypercalcemia and electrolyte disturbances in malignancy","volume":"10","author":"Barri","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ncpneph0622","article-title":"Renal disease in patients with cancer","volume":"3","author":"Finkel","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/092986708783497346","article-title":"Medical treatment of malignancy-associated hypercalcemia","volume":"15","author":"Lumachi","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","article-title":"Prostate cancer bone metastases promote both osteolytic and osteoblastic activity","volume":"91","author":"Keller","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib51","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2008-0227","article-title":"High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid","volume":"14","author":"Zuradelli","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1445-5994.2007.01580.x","article-title":"Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid","volume":"38","author":"Chennuru","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib53","series-title":"Cancer and the kidney","first-page":"35","article-title":"Fluid and electrolyte disorders associated with cancer","author":"Kumar","year":"2005"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5414\/CNP70431","article-title":"Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting\u2014a case report and review of the literature","volume":"70","author":"Woznowski","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib55","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"de Beur","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1742-1241.2007.01674.x","article-title":"Refeeding syndrome in cancer patients","volume":"62","author":"Marinella","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib57","first-page":"11","article-title":"Refeeding syndrome: an important aspect of supportive oncology","volume":"7","author":"Marinella","year":"2009","journal-title":"J Support Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2009.17","article-title":"Fluid, electrolyte and acid-base disorders associated with antibiotic therapy","volume":"5","author":"Zietse","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1991.214","article-title":"Effect of salt supplementation on amphotericin B nephrotoxicity","volume":"40","author":"Llanos","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ncpneph0424","article-title":"Combined renal tubular acidosis and diabetes insipidus in hematological disease","volume":"3","author":"Hoorn","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammopathy","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MD.0b013e318125759a","article-title":"Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review","volume":"86","author":"Friedenberg","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2169\/internalmedicine1962.24.257","article-title":"Lactic acidosis and hypoglycemia associated with acute leukemia","volume":"24","author":"Makino","year":"1985","journal-title":"Jpn J Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib65","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(20011101)92:9<2237::AID-CNCR1569>3.0.CO;2-9","article-title":"Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature","volume":"92","author":"Sillos","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005792-199803000-00001","article-title":"D-lactic acidosis","volume":"77","author":"Uribarri","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib67","first-page":"891","article-title":"D-lactic acidosis in a patient after subtotal colectomy","volume":"5","author":"Kamar","year":"2003","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0609.2005.00547.x","article-title":"Alterations in electrolyte equilibrium in patients with acute leukemia","volume":"75","author":"Filippatos","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.mph.0000161271.68054.b9","article-title":"Electrolyte abnormalities at diagnosis of acute lymphocytic leukemia may be a clue for renal damage in long-term period","volume":"27","author":"Olgar","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<201::AID-AJH1>3.0.CO;2-1","article-title":"Acid-base and electrolyte abnormalities in patients with acute leukemia","volume":"62","author":"Milionis","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.1978.tb03641.x","article-title":"Metabolic disorders in acute myeloid leukaemia","volume":"40","author":"Mir","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00075198-200212000-00005","article-title":"Developing a consensus classification system for acute renal failure","volume":"8","author":"Kellum","year":"2002","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ncpneph0551","article-title":"Improving outcomes of acute kidney injury: report of an initiative","volume":"3","author":"Molitoris","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib74","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ndt\/gfn012","article-title":"Defining and classifying AKI: one set of criteria","volume":"23","author":"Kellum","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib75","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MCC.0b013e32830ef70b","article-title":"Acute renal problems in the critically ill cancer patient","volume":"14","author":"Lameire","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib76","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1001\/jama.288.20.2599","article-title":"Loop diuretics for patients with acute renal failure: helpful or harmful?","volume":"288","author":"Lameire","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.emc.2009.01.001","article-title":"Renal complications in oncologic patients","volume":"27","author":"Givens","year":"2009","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(05)70238-5","article-title":"Acute renal failure","volume":"365","author":"Lameire","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib79","series-title":"Management of acute kidney problems","first-page":"39","article-title":"Intrinsic acute kidney injury","author":"Lameire","year":"2010"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib80","series-title":"Management of acute kidney problems","first-page":"83","article-title":"Clinical and laboratory evaluation","author":"Anderson","year":"2010"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib81","series-title":"Management of acute kidney problems","first-page":"95","article-title":"Kidney function tests and urinalysis","author":"Bagshaw","year":"2010"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000227785","article-title":"Early diagnosis of acute kidney injury: the promise of novel biomarkers","volume":"28","author":"Soni","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","article-title":"Biomarkers of acute kidney injury","volume":"48","author":"Vaidya","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib84","doi-asserted-by":"crossref","first-page":"c192","DOI":"10.1159\/000142928","article-title":"Biomarkers for the diagnosis of acute kidney injury","volume":"109","author":"Waikar","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib85","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib86","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-148-11-200806030-00003","article-title":"Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury","volume":"148","author":"Nickolas","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccc.2009.09.002","article-title":"Acute kidney injury in critically ill patients with cancer","volume":"26","author":"Benoit","year":"2010","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib88","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","article-title":"Characteristics and outcomes of cancer patients in European ICUs","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib89","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/CCM.0B013E318165FC5A","article-title":"Reevaluating prognosis: cancer, septic shock, and changing outcomes","volume":"36","author":"Thomas","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib90","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5414\/CNP68186","article-title":"Tumor lysis syndrome and acute renal failure\u2014an increasing spectrum of presentations","volume":"68","author":"Mukherjee","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.critrevonc.2007.05.003","article-title":"Tumor lysis syndrome in elderly","volume":"64","author":"Pumo","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib93","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1093\/ndt\/gfp330","article-title":"A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome","volume":"24","author":"Shimada","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib95","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfh637","article-title":"Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies","volume":"20","author":"Benoit","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib96","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00520-003-0588-8","article-title":"Continuous venovenous haemofiltration in cancer patients with renal failure: a single-centre experience","volume":"12","author":"Berghmans","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00134-007-0579-1","article-title":"Should dialysis be offered to cancer patients with acute kidney injury?","volume":"33","author":"Darmon","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib98","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2006.05.7869","article-title":"Prognosis of critically ill patients with cancer and acute renal dysfunction","volume":"24","author":"Soares","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib99","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2005.03.9073","article-title":"Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports","volume":"24","author":"Pene","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semnephrol.2010.09.002_bib100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2215\/CJN.02130309","article-title":"Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients","volume":"4","author":"Salahudeen","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929510001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929510001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T09:52:45Z","timestamp":1544089965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929510001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0270929510001348"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2010.09.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}